eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial

by NASDAQ Market News June 9, 2021

NASDAQ Market News
Click here to email author

BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET

Clover Health to Scale In-home Primary Care Program Through Direct Contracting

Ads